An unusual rise in severe cases of strep A in Australia has prompted calls for a vaccine to prevent the deadly infection.
The number of children admitted to the hospital with strep A rose from 23 in 2020 to 107 in 2022, the Murdoch Children’s Research Institute has found.
The children experienced symptoms including toxic shock syndrome and aggressive skin infections.

The increase in strep A in Australia mirrored a similar increase in the northern hemisphere, despite seasonal differences.
“This increase is probably due to a combination of environmental factors and circulating viruses,” said Dr. Yara-Natalie Abo from the institute.
“More research is needed to determine if new strains could be responsible.”
Streptococcus A causes sore throats, scarlet fever and skin sores, affects an estimated 750 million people worldwide and kills 500,000 a year.
The bacterium disproportionately affects young children, the elderly, pregnant women and indigenous Australians.
There is currently no vaccine to prevent strep A, but researchers are working to find one that is effective and affordable.
“We hope this research will accelerate the development of a vaccine and move towards larger field trials,” said Professor Andrew Steer from the institute.
“A strep A vaccine will save hundreds of thousands of lives every year and prevent millions of infections that send children and adults to the hospital or doctor.”